Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08KEZ
|
|||
Former ID |
DNC003310
|
|||
Drug Name |
Canaline
|
|||
Synonyms |
L-Canaline; 496-93-5; (S)-2-Amino-4-(aminooxy)butanoic acid; O-Amino-L-homoserine; L-Homoserine, O-amino-; UNII-T7H2XP1ZNS; T7H2XP1ZNS; (2S)-2-amino-4-(aminooxy)butanoic acid; L-2-amino-4-(aminooxy)butyrate; L-2-amino-4-(aminooxy)butyric acid; L-a-amino-g-(aminooxy)-n-butyric acid; 2-Amino-4-(aminooxy)butyric acid; L-Canaline base; 1-Amino-3-amino-oxybutyric acid; AC1L9B6J; SCHEMBL440859; CHEMBL1231652; CTK1D6980; DTXSID60197925; MolPort-019-904-731; FQPGMQABJNQLLF-VKHMYHEASA-N; ZINC1531042; ANW-63284; AKOS006274866; L-canaline
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1], [2] | |
Structure |
Download2D MOL |
|||
Formula |
C4H10N2O3
|
|||
Canonical SMILES |
C(CON)C(C(=O)O)N
|
|||
InChI |
1S/C4H10N2O3/c5-3(4(7)8)1-2-9-6/h3H,1-2,5-6H2,(H,7,8)/t3-/m0/s1
|
|||
InChIKey |
FQPGMQABJNQLLF-VKHMYHEASA-N
|
|||
CAS Number |
CAS 496-93-5
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:41401
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Ornithine delta-aminotransferase (OAT) | Target Info | Inhibitor | [1], [2] |
BioCyc | Ornithine de novo biosynthesis | |||
KEGG Pathway | Arginine and proline metabolism | |||
Metabolic pathways | ||||
Biosynthesis of antibiotics | ||||
Pathwhiz Pathway | Arginine and Proline Metabolism | |||
Reactome | Amino acid synthesis and interconversion (transamination) | |||
WikiPathways | Urea cycle and metabolism of amino groups | |||
Metabolism of amino acids and derivatives |
References | Top | |||
---|---|---|---|---|
REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
REF 2 | Ornithine aminotransferase, a potential target for the treatment of hyperammonemias. Curr Drug Targets. 2000 Sep;1(2):119-53. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.